BN BN
Company Profile ↓Company Overview
BN (BN) is a publicly traded company listed on with a market capitalization of $108.15B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Operating margin of 24.0% supports profitability.
Recent Developments
- Dec 2025 Revenue of $75.10B (-12.7% YoY); net profit $1.31B.
- Trailing 12 Months Year-on-year growth — revenue -12.7%, earnings +103.9%.
- 5-Year Trend Long-term compounding — revenue CAGR -6.8%, profit CAGR -14.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -6.80% |
| 1 Year: | -12.68% |
Compounded Profit Growth
| 5 Years: | -14.02% |
| 1 Year: | 103.90% |
Stock Price Performance
| 1 Year: | +0.89% |
| 6 Months: | +0.13% |
| 3 Months: | -2.69% |
| 1 Month: | +1.71% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)59.83 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading at a high P/E of 90.9.
- Revenue declined at -6.8% CAGR over 5 years.
- Earnings shrank at -14.0% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 17.94B | 18.08B | 18.92B | 20.16B | 18.58B |
| Cost of Revenue | - | 13.45B | 13.91B | 14.63B | 14.98B | 14.14B |
| Gross Profit | - | 4.49B | 4.17B | 4.29B | 5.18B | 4.44B |
| Operating Expenses | - | 18.00M | 20.00M | 18.00M | 22.00M | 20.00M |
| Operating Income | - | 4.48B | 4.15B | 4.27B | 5.16B | 4.42B |
| EBITDA | - | 7.21B | 7.98B | 7.79B | 8.87B | 8.42B |
| Interest Expense | - | 4.16B | 4.25B | 4.31B | 4.37B | 4.35B |
| Pretax Income | - | 598.00M | 1.19B | 788.00M | 1.79B | 1.44B |
| Tax Provision | - | 383.00M | 134.00M | 504.00M | 114.00M | 398.00M |
| Net Income | - | 73.00M | 272.00M | 219.00M | 743.00M | 102.00M |
| Diluted EPS | - | 0.01 | 0.15 | 0.08 | 0.30 | 0.03 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 92.77B | 95.92B | 86.01B | 75.10B |
| Cost of Revenue | - | 78.51B | 81.41B | 67.94B | 56.97B |
| Gross Profit | - | 14.26B | 14.52B | 18.07B | 18.13B |
| Operating Expenses | - | 122.00M | 69.00M | 76.00M | 78.00M |
| Operating Income | - | 14.14B | 14.45B | 17.99B | 18.05B |
| EBITDA | - | 25.05B | 30.69B | 29.19B | 31.85B |
| Interest Expense | - | 10.70B | 15.50B | 16.61B | 17.10B |
| Pretax Income | - | 6.66B | 6.12B | 2.83B | 4.37B |
| Tax Provision | - | 1.47B | 1.01B | 982.00M | 1.14B |
| Net Income | - | 2.06B | 1.13B | 641.00M | 1.31B |
| Diluted EPS | - | 1.19 | 0.61 | 0.21 | 0.49 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 441.28B | 490.10B | 490.42B | 518.97B |
| Current Assets | - | 53.39B | 46.70B | 56.17B | 65.08B |
| Cash & Equivalents | - | 14.40B | 11.22B | 15.05B | 16.24B |
| Inventory | - | 9.11B | 7.06B | 5.42B | 5.92B |
| Receivables | - | 19.49B | 20.26B | 20.28B | 22.77B |
| Total Liabilities | - | 299.39B | 321.85B | 325.04B | 352.78B |
| Current Liabilities | - | 77.75B | 91.13B | 72.31B | 76.99B |
| Long Term Debt | - | 170.78B | 176.11B | 197.33B | 220.80B |
| Total Debt | - | 214.07B | 233.71B | 234.79B | 259.61B |
| Total Equity | - | 43.75B | 45.78B | 45.98B | 47.89B |
| Shares Outstanding | - | 1.64B | 1.61B | 1.61B | 2.43B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 8.75B | 6.47B | 7.57B | 10.96B |
| Investing Cash Flow | - | -39.65B | -29.76B | -29.96B | -31.78B |
| Financing Cash Flow | - | 32.46B | 19.93B | 26.90B | 21.69B |
| Capital Expenditure | - | -7.24B | -8.07B | -11.17B | -14.75B |
| Free Cash Flow | - | 1.51B | -1.60B | -3.60B | -3.79B |
| Net Change in Cash | - | 1.72B | -3.38B | 4.29B | 939.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 15.4% | 15.1% | 21.0% | 24.1% |
| Operating Margin % | - | 15.2% | 15.1% | 20.9% | 24.0% |
| Net Margin % | - | 2.2% | 1.2% | 0.7% | 1.7% |
| ROE % | - | 4.7% | 2.5% | 1.4% | 2.7% |
| ROCE % | - | 3.9% | 3.6% | 4.3% | 4.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BN
Brookfield Property Partners Declares Quarterly Distributions on Preferred Units - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOUE0xQjN0UEpiYTVoc3AyMTdndGFMYTlBbl84NXItcGJRS2VxTDluTDRhT1JhTGtxYkhCNkN0VHdkRExVTFJhWVgtbVZWa241VnYzRDAtY0RkOWtpZ3ZFUG5zZVloTGVWVDhBdDhHTko2dHR0QVIyRHdKbWhoT2pmU2NiLWdLSy1PSkVGNm…
Saudi-led group completes $55bn purchase of gaming giant EA - BBC
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5jVUEzbFU3UTZaMUZveGpGLThrTmU2YzVtY2ZQZGlCbFJHU01vb0pWLWdiU1NzQzZianpaYVJYSlQ1V0N2aUl4LXg2Mzl5dXNPVVNFVVpDdU1TZw?oc=5" target="_blank">Saudi-led group completes $55bn purchase of g…
Brookfield (TSX:BN) Stock Still Looks Expensive Despite Its $180b Insurance Push - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNLUIwYVY0N0xpN3pOclRwd1pibmFDVHp3WVVPZWp0N3h1VW56NFR2TGNVMDZqbk43eFZoVnpiSUd2N0VBd0FGUXAzX1Rqb081d29mcExTTklsY2RuQkRNWG9oRFhaeExuWktuSFhIZ2pZc1JVeU1GTUtNNllpWlBWTWZPeGQwbVJraE1lcE…
AstraZeneca shares slump after $400bn BMS merger rumours - Pharmaceutical Technology
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNLVZEcXV5RDVubmFtbDJCd0M0SXJUQW9mcXRBZ2poZEFhTTY5YmFPTHZ5aHdlODJxUjloWG5EcThyT3hpMjhRX0hMcHhCdE1kUFlrMGQ2SklWcG8xYnVRaEFod0V2eTJ6OUg4dU4xU0JlaTRfRm9KM3dfWGNMRm15YTFIVllFR1ZqOEk1V3…
TPG nabs lion’s share of $17bn target for TPG X, third healthcare fund - buyoutsinsider.com
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOU2lKVVhGamdKY3F6R1QwOEp3cHhnZ3ZrV0xLd3BnLVFuY3N1V3VEeVdaQjJGSWVKT3pMWWFOcnFWdktsMUNfTGRETG9oRzdlbmZMWTBCZS1BNjBUNDlTVGd3dGJDdjdMVHN5eUxMdzhWTHZBN0VjYUk0V3B4bEtlVXo5WU9oTnRrY3pFMD…
SK Hynix-owned Solidigm seeks up to $7 bn in pre-IPO share sale - KED Global
<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9TSHV6WVllc3JMMGxEbzhScllsMVlCUGVvMlFBN1laUkYtMjlTeWZpWlFWSE1vN0MtZlItV29jLXpsaW9CelpIeWhqeXNwVjMxOEx0WldFUzIzNS1qWURYdE1CVk94aHhmXzRj?oc=5" target="_blank">SK Hynix-owned Solidigm…
BN — Frequently Asked Questions
What is the current share price of BN?
As of 2026-08-05 17:25 PDT, BN trades at $44.54 on NASDAQ/NYSE. Its 52-week range is $38.20 to $49.01.
What is the market capitalisation of BN?
BN has a market capitalisation of $108.15B on NASDAQ/NYSE.
What is the P/E ratio of BN?
BN trades at a trailing price-to-earnings (P/E) ratio of 90.90. Its price-to-book (P/B) ratio is 2.26.
What is the return on equity (ROE) of BN?
BN has a return on equity (ROE) of 2.73%. Its return on capital employed (ROCE) is 4.08%.
Is BN a good stock to buy?
This page provides a data-driven analysis of BN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.